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Salmonid red blood cells are the main target cells for Piscine orthoreovirus (PRV).
Three genotypes of PRV (PRV-1,2,3) infect Atlantic salmon (Salmo salar), Chinook
salmon (Onchorhynchus tshawytscha), Coho salmon (Oncorhynchus kisutch), rainbow
trout (Onchorhynchus mykiss) and brown trout (Salmo trutta), and can cause diseases
like heart and skeletal muscle inflammation (HSMI), jaundice syndrome, erythrocyte
inclusion body syndrome (EIBS) and proliferative darkening syndrome (PDS). Purified
PRV administrated to fish has proven the causality for HSMI and EIBS. During the early
peak phase of infection, salmonid erythrocytes are the main virus-replicating cells. In
this initial phase, cytoplasmic inclusions called “virus factories” can be observed in the
erythrocytes, and are the primary sites for the formation of new virus particles. The
PRV-infected erythrocytes in Atlantic salmon mount a strong long-lasting innate antiviral
response lasting for many weeks after the onset of infection. The antiviral response of
Atlantic salmon erythrocytes involves upregulation of potential inhibitors of translation.
In accordance with this, PRV-1 protein production in erythrocytes halts while virus RNA
can persist for months. Furthermore, PRV infection in Coho salmon and rainbow trout are
associated with anemia, and in Atlantic salmon lower hemoglobin levels are observed.
Here we summarize and discuss the recently published findings on PRV infection,
replication and effects on salmonid erythrocytes, and discuss how PRV can be a useful
tool for the study of innate immune responses in erythrocytes, and help reveal novel
immune functions of the red blood cells in fish.
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PISCINE ORTHOREOVIRUS (PRV) TARGETS SALMONID
ERYTHROCYTES
The Piscine orthoreovirus (PRV) was first discovered in 2010 in Atlantic salmon (Salmo salar)
suffering from the disease heart and skeletal muscle inflammation (HSMI) (1). Outbreaks of HSMI
started to appear in Atlantic salmon aquaculture on the Norwegian west coast in 1999 (1, 2),
occurring primarily a couple of months after transfer of salmon from fresh water facilities to
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net pens in the sea. The clinical signs were anorectic fish with
abnormal swimming behavior, and accumulated mortality could
be up to 20% of the population (3). The name of the disease,
HSMI, was given due to the typical histological lesions; extensive
heart inflammation starting with mononuclear infiltration of
the epicardium which moves into the myocardium along with
increased severity of the disease (3–5). Initial experimental trials
showed transmission of HSMI to healthy fish after injection of
heart homogenate, and a virus was suspected (6). However, it
took ten more years before PRV was finally identified by RNA
sequencing in 2010, in tune with the development in sequencing
technology (1). In silico analyses of the viral genome defined PRV
as the first orthoreovirus fully sequenced from fish, related to
mammalian and avian orthoreoviruses (MRV, ARV) (7–10). PRV
also has similarities to the grass carp reovirus (GCRV), which
belong to the aquareoviruses. The compelling proof of causality
between PRV andHSMI inAtlantic salmonwas produced in 2017
when injected virus particles purified from fish blood were shown
to transfer HSMI (11).
When antisera were developed to detect PRV in situ in
sections from HSMI hearts, a surprising finding was made:
the virus was not only present in cardiomyocytes, but also in
unidentified blood cells (4). The infection of blood cells preceded
the myocardial infection, and this was confirmed in experimental
PRV infection (12). The findings of the latter study showed that
the red blood cells (RBC), or erythrocytes, were the primary
target cells for PRV in the primary phase of infection (12).
Electron microscopy of the erythrocytes revealed cytoplasmic
globular inclusions, which at the peak of infection were filled with
reovirus-like particles (12) (Figure 1).
Orthoreoviruses have a segmented, double stranded RNA
genome and replicate in the cellular cytoplasm. The virus particle,
primarily based on studies of MRV, consists of eight structural
proteins, whereas three non-structural proteins serve supportive
functions related to the replication process in the infected cell
(9). Orthoreoviruses have a double protein capsid with an inner
core containing the genome, and an outer capsid with protruding
surface proteins that can interact with cell surface receptors
and glycans (13). Membrane interaction between orthoreoviruses
and their cellular receptors trigger endocytosis, and in the
endosome the outer reovirus capsid is partly digested, a process
which exposes hydrophobic domains and triggers endosomal
membrane penetration of the virus. Orthoreoviruses can also be
subject to proteolysis in the extracellular environment, like the
gut, into infectious subviral particles (ISVPs) which can cross the
plasma membrane in a receptor-independent manner (14). In
the cytoplasm the viral particle ends up as a stripped virus core
containing the dsRNA genome, and the genome is transcribed
and replicated by the virus’ own RNA polymerase within the core.
The resulting transcripts are further translated by the cellular
translation system. A central protein isµNS, encoded by the virus
segment M3. The µNS protein acts as a scaffold and bring the
virus proteins together in the specific subcellular compartments
(15–17). The PRV µNS protein will, when overexpressed in fish
cells, form globular cytoplasmic clusters by itself, that resemble
the clusters found in PRV-infected erythrocytes (18). PRV µNS
directly interacts with several other PRV proteins, recruiting
FIGURE 1 | Purification of PRV from infected RBCs and PRV genotypes.
(A) Micrograph of PRV infected erythrocyte with virus-containing inclusions in
the cytoplasm (arrowhead). (B) Purification of PRV from infected blood cells
results in virus band in CsCl gradient. (C) Electron microscopy image of
purified PRV particles (Bar equals 100 nm). (D) Overview of PRV genotypes
and associated diseases.
them to these clusters which are considered the production
sites for viral progeny, so called “viral factories” (18). The virus
factories increase in size but decrease in number during the virus
cycle.
Fish red blood cells are nucleated and morphologically
different from mammalian erythrocytes, with additional
functions (19, 20). PRV infection in the red blood cells was
discovered soon after first report on innate immune cell
functions of rainbow trout erythrocytes, which were shown to
respond to the dsRNA mimic poly(I:C) (19). The initial studies
of PRV-infected erythrocytes revealed that the viral factories,
consisting of PRV proteins and viral progeny, were also visible
in a regular light microscope as dark spots in the red blood cells
(12, 21). This visual image of dense cytoplasmic inclusions led to
an assumption that PRV could also be responsible for a disease
with a hitherto undefined etiology; the erythrocyte inclusion
body syndrome (EIBS) (22, 23). EIBS had been described in
wild and farmed salmonids in several countries as a disease with
pathological characteristics different from HSMI, most strongly
associated with anemia (23). A new PRV variant was identified in
Coho salmon (Onchorynchus kisutch) suffering from EIBS, and
purified virus was shown to form the inclusions typical for EIBS
and anemia when given to fish experimentally (24). This PRV
variant was named PRV-2.
To further link different pathological symptoms with PRV
infection, another PRV genotype was detected in farmed
rainbow trout (Onchorhynchus mykiss) in Norway, associated
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with both heart inflammation and anemia (25). Infection
experiments performed with this PRV genotype, initially called
PRV-Om (Onchorhynchus mykiss) in contrast to PRV-Ss (Salmo
salar)/PRV-1, demonstrated formation of virus factory like
structures in the cytoplasm of RBC. The rainbow trout PRV
genotype is now referred to as PRV-3 (26).
PRV-Om/PRV-3 could infect both rainbow trout and Atlantic
salmon, but preferably infected and caused disease in rainbow
trout, whereas transmission and ability to cause disease in
Atlantic salmon was negligible (27). In Chile, both PRV-Ss/PRV-1
and PRV-Om/PRV-3 was detected in rainbow trout (28).
The novel PRV genotypes have similar dissemination
pattern and pathogenesis, but show preferences and differential
pathogenicity for different salmonid species. The best established
diseases are shown in table/Figure 1D. In addition, PRV-1 was
recently associated with Jaundice syndrome in Chinook salmon
(Oncorhynchus tshawytscha) (29); and PRV-3 with proliferative
darkening syndrome (PDS) in Brown trout (Salmo trutta) (30).
PRV-1-3 all have erythrocytes as their main target cells in
the initial peak phase of infection. The infected red blood cells
contribute to the further virus dissemination to various host
tissue, and the effects of PRV on erythrocytes in the different
species may provide a key to an explanation of subsequent
pathogenesis (11, 24, 27, 29).
EFFECTS OF PRV INFECTION ON
ERYTHROCYTE GENE EXPRESSION AND
FUNCTION
The responses to PRV infection have been studied using DNA
oligonucleotide microarray on red blood cells isolated from
PRV-infected fish after experimental infection. These analyses
revealed that that the infected erythrocytes strongly up-regulate
a large group of genes associated with antiviral responses (31)
(Figure 2A), similar to other tissues infected with RNA viruses
in Atlantic salmon (32). The antiviral response correlated closely
with increasing PRV levels in the red blood cells indicating that
sensing and replication were linked in the early phase.
The main inducer of the antiviral response is cellular sensing
of the PRV dsRNA genome. Two types of pattern recognition
receptors (PRRs) are involved in dsRNA sensing in fish: the
transmembrane dsRNA sensor toll-like receptor (TLR)3 in the
endosomes and the cytoplasmic RIG-like receptors (RLRs) (33,
34). Trout red blood cells have been reported to express TLR3 and
RIG-I (19), and induction by PRV was confirmed in red blood
cells (19, 31). Fish cells also express TLR22 and TLR19, which are
comparable to TLR3 by function, but is expressed primarily on
the cell surface (35, 36). In mammals, intact MRV triggers both
TLRs and RLRs, while intermediate subviral particles (ISVPs)
formed by partial proteolysis of the outer viral capsid (e.g., in the
gut) trigger RLRs only, leading to a less potent antiviral response
(14). It is so far unknown if PRV infects RBCs as an intact particle
or an ISVP.
The dsRNA receptors induce transcription of type I
interferons through activation of interferon response factors
(IRFs), which mediates further antiviral effects. Atlantic salmon
FIGURE 2 | (A) Upregulated and (B) downregulated functional groups of
genes in PRV-infected red blood cells.
RBCs express a panel of IRFs, of which expression of IRF7
showed highest correlation with PRV levels (31). In contrast
to the mammalian IFNα and IFNβ, Atlantic salmon type I
interferons form a large family divided into four groups IFNa–
d, with several subtypes for each (37). In mammals, IFNβ
is the main interferon induced by TLR3 and RLRs, and in
line with this, MRV replication is reported to be controlled
by IFNβ (38). Previous studies in fish have indicated that
IFNa (1 and 2) serve similar functions as IFNβ in mammals
(37, 39), which fits well with IFNa2 being one of the genes
expressed with strongest correlation to PRV levels in Atlantic
salmon RBC (31). Another study comparing expression of
IFNa, b and c after PRV infection in a context of PRV cross-
protection against IHNV, revealed preferential induction of
IFNa (40). Secreted interferons bind to interferon receptors
on surrounding cells, triggering a Jak/STAT signaling pathway
leading to expression of multiple antiviral effector genes, which
can inhibit further host dissemination of the virus. PRV-1
infection of Atlantic salmon RBCs induces numerous antiviral
genes (31). Interestingly, among the induced genes correlating
most strongly with PRV levels were the signaling mediators
STAT1 and Jak1 themselves (17). The second largest gene group
to be induced by PRV infection in RBC was genes involved in
viral antigen presentation, includingMHC class I antigen, tapasin
and several proteosome subunits (31). This suggests that infected
erythrocytes have the capability of presenting viral antigens to
the immune system. A recent transcriptome/proteome study
reported that rainbow trout RBC also express MHC Class
II, (41). This points to salmonid erythrocytes as inducers of
adaptive immunity. Another interesting finding in PRV-infected
Atlantic salmon erythrocytes was that genes associated with
immune suppression, like Interleukin 10 receptor and suppressor
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of cytokine signaling (SOCS) 1, was induced (31). SOCS1 is
shown to suppress pathogen signaling and promote replication
of salmonid alphavirus (SAV) in salmonid cell lines (42).
Interestingly, PRV infection is cross-protective against SAV (43).
Responses of red blood cells have also been observed in
Atlantic salmon infected with Piscine myocarditis virus (PMCV),
a small dsRNA virus associated with cardiomyopathy syndrome
(CMS) (44). Notably, PMCV is not shown to replicate in
erythrocytes. This indicates that the RBC innate immune
responses to viruses are induced independent of direct infection,
which is also in line with reported responses to infectious
pancreas necrosis virus (IPNV) (45).
Interestingly, we found that purified Atlantic salmon red
blood cells infected with PRV in culture also induced IFNa in
culture with subsequent induction of Mx and PKR, indicating
that infected RBC produce functional IFNa (21). An interesting
observation from RBC responses in culture, was the time course
of PRV-mediated IFN and antiviral gene expression compared to
the in vivo situation. In culture, IFNa expression peaked after
1 day and the antiviral effector genes after 1 week, followed
by a decrease to basal levels after 2–3 weeks. The fact that the
response did not decrease for months in vivo could point toward
continuous infection of new RBCs, or to interferon stimulation
from other sources.
Experimental infection of PRV-1 in Atlantic salmon and PRV-
3 in rainbow trout has confirmed that PRV infects RBC prior
to infection and induction of inflammatory lesions in the heart
(11, 27). The same PRV-1 genotype have been associated with
infection other target organs and differential disease pathology in
Chinook salmon, where the disease is characterized by necrosis
and degeneration in kidney and liver (29). Di Cicco et al proposed
that a difference in PRV load tolerance in the RBC could be
one reason for differential pathological outcomes from PRV-1
infection in the different species. Similarly, PRV-3 have been
reported to infect both rainbow trout and Brown trout with
differential outcomes (25, 30). Whereas, Heart inflammation and
anemia was the most notable findings in farmed rainbow trout
(25), wild brown trout suffered from proliferative darkening
syndrome (PDS), a high mortality disease characterized by
necrotic lesions and degeneration of the liver and to a lesser
degree spleen and kidney (30). Hence, both PRV-1 and PRV-3
appear to cause species-specific diseases.
While PRV-3 appear to be cleared from blood after infection in
rainbow trout (27), PRV-1 RNA persists in Atlantic salmon blood
long after HSMI has healed and heart tissue has regenerated
(11, 12, 46). The PRV-1 persistence can last for at least 50
weeks (47), which is in line with the >90% prevalence of PRV-
1 detection in farmed Atlantic salmon. It is unknown if PRV-2
or PRV-3 can persist in a similar manner in their host species,
but sustained carrier status has not been observed for these PRV
genotypes so far (24, 27).
When targeting PRV proteins with antibodies instead of
analyzing PRV RNA, a quite different result is obtained. PRV
protein production peaks for a couple of weeks and is then
decreased to undetectable levels (11, 12, 46). This discrepancy
between PRV RNA- and protein levels points to translational
blocking or degradation of viral protein. In line with this, the
protein decrease coincides with the peak gene expression of the
antiviral effectors (46).
When comparing with the mammalian counterpart, MRV has
been reported to counteract the antiviral response in several ways
to support its own replication.Mechanisms of interaction include
binding and inactivation of IRF3 by the PRV µNS protein (14),
or bypassing translational blocking through the PRV σ3 protein
(48). The long lasting transcription of interferon-regulated genes
in PRV-infected A. salmon indicates that PRV does not effectively
block interferon production or interferon-mediated stimulation
of antiviral gene expression in Atlantic salmon RBC. However,
there may be a block at the translational level. The persistence of
PRV RNA along with an apparent block in progeny production
points toward ineffective eradication of infected RBC, while
viral dissemination appears to be held back by innate immune
mechanisms.
When comparing antiviral responses to PRV-1 and PRV-3
cross-species, data so far indicate that the magnitude of innate
antiviral responses corresponds to virulence in the respective
target species (PRV-1 in A. salmon and PRV-3 in rainbow trout).
Although PRV-1 can replicate intensely in Coho salmon and
Sockeye salmon (O. nerka) blood cells, the antiviral response
to PRV-1 in Sockeye salmon is reported to be very low (49).
Similarly, PRV-3 replicates in Atlantic salmon blood but induce
weak antiviral response. This implies that the pathologic effects of
PRV infection could be coupled to the ability to induce antiviral
immune responses in the host.
Anemia is reported as a hallmark for PRV-2 infected Coho
salmon, and typical for PRV-3 infected farmed rainbow trout
(24, 25). In an infection that can affect up to 50% of the
erythrocytes in the peak phase, anemia is not unexpected.
However, experimental studies of PRV-3 infected rainbow trout
have not reproduced the anemia observed in field outbreaks (12,
27). Similarly, anemia is not produced in PRV-1 experimental
trials (11), and not commonly observed in farmed PRV-1
infected A. salmon in Norway. In contrast, reports from Chile
have indicated that 19% of HSMI diseased fish had pale gills
and heart, which could indicate anemia (50). Genes associated
with erythropoiesis are found to be induced in spleen after
PRV infection in Atlantic salmon (51), indicating that cleared,
erythrocytes are replaced efficiently enough to avoid anemia.
However, a reduction in hemoglobin is observed in PRV-infected
RBC in the period after the peak virus production in blood
(11, 52). The hemoglobin reduction is observed after the peak
in virus levels, suggesting that it may be caused by the same
translational block that reduces production of viral progeny
(11, 46). A direct effect of PRV-1 infection on the ability of
Atlantic salmon to tolerate hypoxia was revealed in a stress
test experiment, which indicated that PRV-infected fish could
be more prone to mortality due to stress or crowding at
suboptimal oxygen conditions (52), possibly due to hemoglobin
reduction.
The transcriptome study of PRV-1 infected RBCs indicated
a general decrease in the expression of a range of functional
gene groups. Although not fully understood in relation to
implications, the expression patterns strongly indicated that
PRV infection repressed genes that controlled erythrocyte
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shape/cytoskeleton, tissue interaction/adhesion, cell-cell
communication/cytokines/chemokines and metabolism (31)
(Figure 2B). This effect could be caused by infection and
antiviral immunity. In addition, adrenergic stress responses are
reported to reduce transcript stability in fish red blood cells (53),
and could be partly responsible for this effect.
Among the genes less suppressed by the infection were
genes directly related to heme and hemoglobin synthesis,
which supports the hypothesis that the hemoglobin reduction
associated with EIBS and HSMI is primarily due to post
trancriptional effects. Strong reduction in adhesion molecule
expression implies that the ability of RBC to interact with muscle
tissue for oxygen delivery could be affected, and thereby add to
the physiological consequences of hemoglobin reduction. When
keeping in mind that a translational inhibition may further
add to suppression at the transcriptional level, disturbed gas
exchange to muscle tissue would not be a surprising result.
Clarifying if these findings are coupled to PRV-mediated disease
will be an important step forward. In addition, the study of PRV
infection is a key to understanding the immunological role of
fish erythrocytes.
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